Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2010-06-28 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VIENNE (38200), Isere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
NOUVELLE PHARMACIE NORMALE : revenue, balance sheet and financial ratios
NOUVELLE PHARMACIE NORMALE is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VIENNE (38200),
this company of category PME
shows in 2016 a revenue of 1.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - NOUVELLE PHARMACIE NORMALE (SIREN 523400307)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1 382 166 €
Net income
-16 393 €
44 248 €
96 954 €
109 135 €
67 474 €
57 613 €
75 037 €
65 251 €
63 019 €
52 834 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
61 981 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
3.8%
Revenue and income statement
In 2025, NOUVELLE PHARMACIE NORMALE records a net loss of 16 k€. This deficit will reduce equity on the balance sheet.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-16 393 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 86%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
85.873%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
46.648%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution NOUVELLE PHARMACIE NORMALE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
261.174
220.0
169.655
124.709
98.93
78.296
48.65
36.211
22.987
85.873
Financial autonomy
23.494
27.144
32.129
38.662
43.187
47.997
56.342
64.441
69.42
46.648
Repayment capacity
10.846
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
4.102%
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
85.872025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average+28 pts over 3 years
In 2025, the debt ratio of NOUVELLE PHARMACIE NORMALE (85.87) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
46.65%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average-29 pts over 3 years
In 2025, the financial autonomy of NOUVELLE PHARMACIE NORMALE (46.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 400.92. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
400.919
Liquidity indicators evolution NOUVELLE PHARMACIE NORMALE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
169.63
182.007
205.209
211.663
208.744
212.164
201.391
236.869
231.875
400.919
Interest coverage
17.35
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
400.922025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent+10 pts over 3 years
In 2025, the liquidity ratio of NOUVELLE PHARMACIE NORMALE (400.92) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution NOUVELLE PHARMACIE NORMALE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
187 339 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
47
0
0
0
0
0
0
0
0
0
Customer payment term (days)
6
0
0
0
0
0
0
0
0
0
Supplier payment term (days)
39
0
0
0
0
0
0
0
0
0
Positioning of NOUVELLE PHARMACIE NORMALE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare NOUVELLE PHARMACIE NORMALE with other companies in the same sector:
Frequently asked questions about NOUVELLE PHARMACIE NORMALE
What is the revenue of NOUVELLE PHARMACIE NORMALE ?
The revenue of NOUVELLE PHARMACIE NORMALE in 2016 is 1.4 M€.
Is NOUVELLE PHARMACIE NORMALE profitable?
NOUVELLE PHARMACIE NORMALE recorded a net loss in 2025.
Where is the headquarters of NOUVELLE PHARMACIE NORMALE ?
The headquarters of NOUVELLE PHARMACIE NORMALE is located in VIENNE (38200), in the department Isere.
Where to find the tax return of NOUVELLE PHARMACIE NORMALE ?
The tax return of NOUVELLE PHARMACIE NORMALE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does NOUVELLE PHARMACIE NORMALE operate?
NOUVELLE PHARMACIE NORMALE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart